Eli Lilly and Company Stock News

Eli Lilly (LLY 4.33%) stock hasn't been doing too well this year, but that could change later this month. A couple of key events are on the horizon this month during which the company will release new data from studies relating to multiple GLP-1 drugs.

Talks with the Trump administration about lowering U.S. drug prices have so far not provided clarity on when and how reduced prices will be implemented, top executives from Eli Lilly and Merck said at an industry conference on Tuesday.

Eli Lilly and Company (NYSE:LLY ) Goldman Sachs 46th Annual Global Healthcare Conference June 10, 2025 8:00 AM ET Company Participants Lucas E. Montarce - Executive VP & CFO Michael Czapar - Director of Investor Relations Conference Call Participants Unidentified Analyst Get started here.

The article presents the highest-quality Dividend Contenders, companies listed on U.S. exchanges with higher annual dividend payouts for 10-24 consecutive years. I use a quality scoring system with six quality indicators, each worth five points, for a maximum score of 30. The highest-quality Dividend Contenders score four or five points for each quality indicator.

Is there a hotter trend in healthcare than weight loss drugs? Probably not.

Justin Sullivan / Getty Images Visa Fintech is changing the world and Visa is at the center of it.

These companies are more profitable than they were a year ago. They are also expected to put up huge sales growth numbers through 2027.

With the stock market settling in after a volatile period, now is a good time to start looking at some leading growth stocks that have strong potential over the next decade.